The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Cole Hugh M since year 2005.
The trader's CIK number is 1604646.
At the time of this reporting, Cole Hugh M is the Chief Business Officer of Jounce Therapeutics, Inc. .
(stock ticker symbol JNCE).
See this page for all insider trading activities at Jounce Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-06-15||JNCE||Jounce Therapeutics, Inc.||Buy||1,900||7.84||14,896|
|2015-06-25||ARIA||Ariad Pharmaceuticals Inc||Option Ex||19,167||.00||0|
|2016-06-28||ARIA||Ariad Pharmaceuticals Inc||Sale||6,012||7.05||42,384|
|2016-06-27||ARIA||Ariad Pharmaceuticals Inc||Option Ex||19,166||.00||0|
|2016-03-16||ARIA||Ariad Pharmaceuticals Inc||Option Ex||7,500||6.21||46,575|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cole Hugh M (Chief Business Officer of Jounce Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.